Senzar Asset Management Has Upped Its Aerie Pharmaceuticals (AERI) Stake by $2.78 Million; Valuation Declined; 3M Co (MMM) Shareholder Garland Capital Management Cut Its Stake as Valuation Declined

April 19, 2018 - By Nellie Frank

3M Company (NYSE:MMM) Logo

Garland Capital Management Inc decreased its stake in 3M Co (MMM) by 9.45% based on its latest 2017Q4 regulatory filing with the SEC. Garland Capital Management Inc sold 2,660 shares as the company’s stock declined 8.03% with the market. The institutional investor held 25,492 shares of the medical and dental instruments company at the end of 2017Q4, valued at $6.00M, down from 28,152 at the end of the previous reported quarter. Garland Capital Management Inc who had been investing in 3M Co for a number of months, seems to be less bullish one the $130.55 billion market cap company. The stock decreased 0.26% or $0.57 during the last trading session, reaching $219.52. About 1.60M shares traded. 3M Company (NYSE:MMM) has risen 13.36% since April 19, 2017 and is uptrending. It has outperformed by 1.81% the S&P500.

Senzar Asset Management Llc increased its stake in Aerie Pharmaceuticals Inc (AERI) by 20.42% based on its latest 2017Q4 regulatory filing with the SEC. Senzar Asset Management Llc bought 47,200 shares as the company’s stock declined 12.77% with the market. The hedge fund held 278,400 shares of the health care company at the end of 2017Q4, valued at $16.64M, up from 231,200 at the end of the previous reported quarter. Senzar Asset Management Llc who had been investing in Aerie Pharmaceuticals Inc for a number of months, seems to be bullish on the $2.15 billion market cap company. The stock decreased 1.18% or $0.65 during the last trading session, reaching $54.5. About 115,293 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 16.25% since April 19, 2017 and is uptrending. It has outperformed by 4.70% the S&P500.

Analysts await 3M Company (NYSE:MMM) to report earnings on April, 24 before the open. They expect $2.50 EPS, up 15.74% or $0.34 from last year’s $2.16 per share. MMM’s profit will be $1.49 billion for 21.95 P/E if the $2.50 EPS becomes a reality. After $2.10 actual EPS reported by 3M Company for the previous quarter, Wall Street now forecasts 19.05% EPS growth.

Among 16 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 4 Sell and 5 Hold. Therefore 44% are positive. 3M had 83 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Underweight” rating by JP Morgan given on Wednesday, September 20. The stock has “Sell” rating by Goldman Sachs on Monday, November 21. Barclays Capital maintained 3M Company (NYSE:MMM) rating on Monday, March 26. Barclays Capital has “Underweight” rating and $230 target. On Monday, May 29 the stock rating was maintained by Jefferies with “Buy”. As per Wednesday, December 16, the company rating was maintained by UBS. As per Tuesday, July 25, the company rating was maintained by RBC Capital Markets. The stock of 3M Company (NYSE:MMM) has “Buy” rating given on Friday, April 28 by Barclays Capital. The stock of 3M Company (NYSE:MMM) has “Underperform” rating given on Tuesday, August 4 by RBC Capital Markets. Jefferies maintained 3M Company (NYSE:MMM) on Monday, August 14 with “Buy” rating. The stock of 3M Company (NYSE:MMM) has “Buy” rating given on Tuesday, September 26 by Jefferies.

Investors sentiment increased to 0.83 in 2017 Q4. Its up 0.06, from 0.77 in 2017Q3. It improved, as 47 investors sold MMM shares while 635 reduced holdings. 147 funds opened positions while 416 raised stakes. 383.04 million shares or 1.04% less from 387.06 million shares in 2017Q3 were reported. Park Avenue Securities has invested 0.11% in 3M Company (NYSE:MMM). North Star Investment Management has 0.31% invested in 3M Company (NYSE:MMM) for 10,936 shares. Moreover, Stewart And Patten Co Limited Liability Company has 5.23% invested in 3M Company (NYSE:MMM) for 124,387 shares. Weik Capital Management invested in 1.97% or 17,892 shares. Webster Bancorporation N A has 21,659 shares for 0.7% of their portfolio. Hancock Hldgs invested in 3,302 shares or 0.03% of the stock. Hedeker Wealth Lc accumulated 16,948 shares. Eqis Mngmt Inc holds 0.15% or 12,648 shares in its portfolio. Fairfield Bush & Co owns 5,545 shares or 0.36% of their US portfolio. 1,102 are owned by Jacobson & Schmitt Advsr. Tru Of Virginia Va has 0.43% invested in 3M Company (NYSE:MMM). 15,848 were accumulated by Kentucky Retirement Sys Trust Fund. Department Mb Bank N A holds 2,604 shares or 0.06% of its portfolio. West Oak Capital Limited Liability reported 0.29% in 3M Company (NYSE:MMM). Guardian Capital Ltd Partnership has 13,025 shares.

Since October 27, 2017, it had 0 insider buys, and 21 insider sales for $34.51 million activity. Shin Hak Cheol sold $2.00 million worth of stock or 8,014 shares. 400 shares were sold by Lindekugel Jon T, worth $92,023 on Tuesday, October 31. 4,146 3M Company (NYSE:MMM) shares with value of $1.02M were sold by Roman Michael F. Gangestad Nicholas C sold 4,004 shares worth $936,291. Bauman James L had sold 8,834 shares worth $2.19M on Friday, February 2. Keel Paul A also sold $3.33 million worth of 3M Company (NYSE:MMM) on Thursday, February 1.

Senzar Asset Management Llc, which manages about $442.00 million and $391.71 million US Long portfolio, decreased its stake in Allergan Plc by 11,200 shares to 48,900 shares, valued at $8.00 million in 2017Q4, according to the filing. It also reduced its holding in Halozyme Therapeutics Inc (NASDAQ:HALO) by 3.29 million shares in the quarter, leaving it with 537,500 shares, and cut its stake in Allergan Plc (Prn).

Investors sentiment decreased to 1.2 in Q4 2017. Its down 0.53, from 1.73 in 2017Q3. It dived, as 23 investors sold AERI shares while 48 reduced holdings. 21 funds opened positions while 64 raised stakes. 34.86 million shares or 1.29% more from 34.42 million shares in 2017Q3 were reported. First Mercantile has 6,787 shares. Polar Capital Llp holds 0.06% or 100,000 shares. Iguana Healthcare Mngmt Ltd Liability, a New York-based fund reported 85,000 shares. Tradewinds Capital Mgmt Limited Company stated it has 0.01% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). New York-based Qs Invsts Limited Liability Corporation has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Schwab Charles Inv Management holds 164,605 shares. Credit Suisse Ag owns 179,503 shares or 0.01% of their US portfolio. Atwood And Palmer reported 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Federated Invsts Inc Pa holds 9,537 shares. Alliancebernstein Limited Partnership holds 371,076 shares. Kazazian Asset Management Ltd has 0.76% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 12,466 shares. Waddell & Reed Fincl reported 455,427 shares. Pennsylvania-based Pnc Services Group Inc has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). 40,673 were reported by Alps Advsr. Voya Inv Mgmt Ltd Liability Com holds 0.05% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) or 397,928 shares.

Among 15 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 50 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, September 17 by Cantor Fitzgerald. The stock has “Buy” rating by Aegis Capital on Tuesday, November 1. H.C. Wainwright reinitiated Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) rating on Friday, February 16. H.C. Wainwright has “Buy” rating and $78 target. Stifel Nicolaus maintained it with “Buy” rating and $7000 target in Thursday, July 27 report. On Friday, October 28 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Wednesday, October 11, the company rating was maintained by Cantor Fitzgerald. H.C. Wainwright maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) rating on Thursday, July 20. H.C. Wainwright has “Buy” rating and $6900 target. As per Wednesday, September 9, the company rating was initiated by JMP Securities. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, September 15. The stock has “Buy” rating by H.C. Wainwright on Wednesday, August 2.

3M Company (NYSE:MMM) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>